In the realm of oncology, genetic mutations are well-established as pivotal factors predisposing individuals to various cancers. Particularly, germline ...

Clarke, PhD, professor at The Hormel Institute, University of Minnesota, is the author of a paper appearing in the scientific ...

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...

Genetic testing on blood or tissue for germline mutations should be performed in certified molecular diagnostic laboratories, for example, Clinical Laboratory Improvement Amendments approved, ISO ...

If you look closely at the fundamental discoveries that have changed human health, physician–scientists have been at the ...

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

Laboratory of Human Genetics & Therapeutics, Smart Health Initiative, Division of Biological and Environmental Science and Engineering (BESE), King Abdullah University of Science and Technology (KAUST ...

A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...

Clinical genetics involves the study, counselling and treatment of individuals and families with heritable disorders and disease predisposition. Diagnostic tools include standard ontologies for ...